Blood News and Research

RSS

Hormonal therapies for breast and prostate cancers increase the risk of heart attack, stroke

The hormonal therapies used to treat many breast and prostate cancers raise the risk of a heart attack and stroke, and patients should be monitored regularly and receive treatment to reduce risk and detect problems as they occur.

26 Apr 2021

Experts develop quality indicators for management and outcomes of adults with atrial fibrillation

Management and outcomes of adults with atrial fibrillation are presented today at EHRA 2021, an online scientific congress of the European Society of Cardiology. The document is published in EP Europace, a journal of the ESC.

26 Apr 2021

Real-world study in India finds COVISHIELD vaccine safe and effective

New research led by Naresh Trehan of Medanta-The Medicity in India found the COVISHIELD (ChAdOx1 nCoV-19 Corona Virus Vaccine) vaccine produced an immune response from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) two weeks after vaccination with limited side effects.

26 Apr 2021

Foot assessments can help detect atrial fibrillation in patients with diabetes

Atrial fibrillation can be detected during annual foot assessments in patients with diabetes, according to research presented today at EHRA 2021, an online scientific congress of the European Society of Cardiology (ESC).

26 Apr 2021

Study to evaluate how people with immune system deficiencies respond to COVID-19 vaccination

A study assessing how people with immune system deficiencies or dysregulations respond to COVID-19 vaccination has begun enrolling participants at the National Institutes of Health Clinical Center in Bethesda, Maryland.

26 Apr 2021

High dose of vitamin D does not have a beneficial effect on moderate or severe COVID-19 patients

Can a high dose of vitamin D administered on admission to hospital improve the condition of patients with moderate or severe COVID-19? The answer is no, according to a Brazilian study published in the Journal of the American Medical Association.

23 Apr 2021

FDA, CDC lift recommended pause on the use of Janssen COVID-19 vaccine in the U.S.

Following a thorough safety review, including two meetings of the CDC's Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.

23 Apr 2021

People with a higher Omega-3 Index lived longer than others, study shows

A new research paper examining the relationship between the Omega-3 Index and risk for death from any and all causes has been published in Nature Communications.

23 Apr 2021

Study links muscle gene to type 2 diabetes

People with type 2 diabetes tend to have poorer muscle function than others. Now a research team at Lund University in Sweden has discovered that in type 2 diabetes, a specific gene is of great importance for the ability of muscle stem cells to create new mature muscle cells.

23 Apr 2021

FDA authorizes marketing of a new device for use in patients undergoing stroke rehabilitation

Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education and for maintaining or increasing range of motion.

23 Apr 2021

Macrophages play a vital role in re-establishing and controlling blood flow after tissue damage

Cardiovascular disease, the most common cause of death, is the result of oxygen deprivation as blood perfusion to affected tissue is prevented.

23 Apr 2021

Study highlights need to integrate critical care-specific needs into disaster response planning

Natural disasters, terrorism attacks, mass shootings and the COVID-19 pandemic have highlighted the importance of disaster response planning throughout the healthcare system.

23 Apr 2021

Researchers identify natural molecule that blocks the binding of human antibodies to SARS-CoV-2

Researchers have found that a natural molecule can effectively block the binding of a subset of human antibodies to SARS-CoV-2. The discovery may help explain why some COVID-19 patients can become severely ill despite having high levels of antibodies against the virus.

23 Apr 2021

Researchers perform cross-sectional analysis to understand the link between insomnia and anemia

A good night's sleep is essential for a healthy body and mind, for when we sleep is when the body resets, repairs, and refreshes itself. A lot of people, however, have trouble falling or staying asleep, a condition known as insomnia that affects up to 30% of the population.

23 Apr 2021

DNA vaccine candidate induces potent immunity, offers protective efficacy in non-human primate models

A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate (NHP) models when given intradermally in abbreviated, low-dose immunization regimen.

23 Apr 2021

COVID-19 survivors have increased risk of death for at least six months

As the COVID-19 pandemic has progressed, it has become clear that many survivors - even those who had mild cases - continue to manage a variety of health problems long after the initial infection should have resolved.

23 Apr 2021

Artificial intelligence helps identify new key-lock pairs against coronavirus

The human immune defense is based on the ability of white blood cells to accurately identify disease-causing pathogens and to initiate a defense reaction against them.

23 Apr 2021

Striking difference identified between mRNA vaccination vs. SARS-CoV-2 infection immune responses

A team of scientists from the United States has recently compared the immune response elicited by natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) vaccination. Their findings reveal that, unlike vaccination, natural SARS-CoV-2 infection is associated with a robust interferon response together with an induction of cytotoxic gene expression in peripheral blood lymphocytes. The study is currently available on the medRxiv* preprint server.

22 Apr 2021

Drug-discovery collaboration finds potential new antimalarial drug candidates

Potential new antimalarial drug candidates are being developed through an extended drug-discovery collaboration between Australian medical research institute WEHI and Janssen Pharmaceutica NV. The collaboration was facilitated by Johnson & Johnson Innovation.

22 Apr 2021

Researchers discover molecule that provides dual protection against vascular inflammation

A multidisciplinary team of researchers from Duke-NUS Medical School and the Agency for Science, Technology and Research (A*STAR) in Singapore discovered a new mitochondrial peptide called MOCCI that plays an important role in regulating inflammation of blood vessel and immunity.

22 Apr 2021

Blood News and Research

Hormonal therapies for breast and prostate cancers increase the risk of heart attack, stroke

Experts develop quality indicators for management and outcomes of adults with atrial fibrillation

Real-world study in India finds COVISHIELD vaccine safe and effective

Foot assessments can help detect atrial fibrillation in patients with diabetes

Study to evaluate how people with immune system deficiencies respond to COVID-19 vaccination

High dose of vitamin D does not have a beneficial effect on moderate or severe COVID-19 patients

FDA, CDC lift recommended pause on the use of Janssen COVID-19 vaccine in the U.S.

People with a higher Omega-3 Index lived longer than others, study shows

Study links muscle gene to type 2 diabetes

FDA authorizes marketing of a new device for use in patients undergoing stroke rehabilitation

Macrophages play a vital role in re-establishing and controlling blood flow after tissue damage

Study highlights need to integrate critical care-specific needs into disaster response planning

Researchers identify natural molecule that blocks the binding of human antibodies to SARS-CoV-2

Researchers perform cross-sectional analysis to understand the link between insomnia and anemia

DNA vaccine candidate induces potent immunity, offers protective efficacy in non-human primate models

COVID-19 survivors have increased risk of death for at least six months

Artificial intelligence helps identify new key-lock pairs against coronavirus

Striking difference identified between mRNA vaccination vs. SARS-CoV-2 infection immune responses

Drug-discovery collaboration finds potential new antimalarial drug candidates

Researchers discover molecule that provides dual protection against vascular inflammation

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News